• Explore /
  • Poster
  • / A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma potential in current real-world practice.

A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma potential in current real-world practice.

Abstract Poster

Authors

null

Kazufumi Kobayashi

Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan;

Kazufumi Kobayashi , Sadahisa Ogasawara , Susumu Maruta , Tomomi Okubo , Michihisa Moriguchi , Hiroaki Kanzaki , Keisuke Koroki , Naoya Kanogawa , Yuki Shiko , Yosuke Inaba , Kazuyoshi Nakamura , Ryosaku Azemoto , Kenji Ito , Shinichiro Okabe , Masanori Atsukawa , Ei Itobayashi , Masafumi Ikeda , Naoki Morimoto , Yoshito Itoh , Naoya Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Clinical Trial Registration Number

s031190017

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 512)

DOI

10.1200/JCO.2023.41.4_suppl.512

Abstract #

512

Poster Bd #

B2

Abstract Disclosures

Similar Posters

First Author: Arndt Vogel

First Author: Timothy J. Brown

First Author: Mathias Earl Palmer

First Author: Claudia A.M. Fulgenzi